Post-GWAS analysis of six substance use traits improves the identification and functional interpretation of genetic risk loci

International Cannabis Consortium

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

BACKGROUND: Little is known about the functional mechanisms through which genetic loci associated with substance use traits ascertain their effect. This study aims to identify and functionally annotate loci associated with substance use traits based on their role in genetic regulation of gene expression.

METHODS: We evaluated expression Quantitative Trait Loci (eQTLs) from 13 brain regions and whole blood of the Genotype-Tissue Expression (GTEx) database, and from whole blood of the Depression Genes and Networks (DGN) database. The role of single eQTLs was examined for six substance use traits: alcohol consumption (N = 537,349), cigarettes per day (CPD; N = 263,954), former vs. current smoker (N = 312,821), age of smoking initiation (N = 262,990), ever smoker (N = 632,802), and cocaine dependence (N = 4,769). Subsequently, we conducted a gene level analysis of gene expression on these substance use traits using S-PrediXcan.

RESULTS: Using an FDR-adjusted p-value <0.05 we found 2,976 novel candidate genetic loci for substance use traits, and identified genes and tissues through which these loci potentially exert their effects. Using S-PrediXcan, we identified significantly associated genes for all substance traits.

DISCUSSION: Annotating genes based on transcriptomic regulation improves the identification and functional characterization of candidate loci and genes for substance use traits.

Original languageEnglish
Article number107703
Pages (from-to)107703
JournalDrug and Alcohol Dependence
Volume206
DOIs
Publication statusPublished - 1 Jan 2020

Bibliographical note

Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Funding

ATM and EMD are supported by the Foundation Volksbond Rotterdam, ATM is supported by the Netherlands Organization of Scientific Research (NWO Vidi grant 016.Vidi.185.044, PI T.J. Galama). ERG is supported by the National Human Genome Research Institute of the National Institutes of Health under Award Number R35HG010718. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. FV is supported by the Investissement d'Avenir program managed by the ANR under reference ANR-11-IDEX-0004-02. KJHV is supported in part by a 2014 NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation. ERG benefited from a Clare Hall Fellowship at the University of Cambridge. The funding sources had no involvement in study design; in the collection, analysis and interpretation of the data; in the writing of the report or the decision to submit for publication.

FundersFunder number
ANR-11-IDEX-0004-02
Foundation Volksbond Rotterdam
Netherlands Organization of Scientific Research
National Institutes of Health
National Human Genome Research InstituteR35HG010718
Brain and Behavior Research Foundation
National Alliance for Research on Schizophrenia and Depression
University of Cambridge
Agence Nationale de la Recherche
Nederlandse Organisatie voor Wetenschappelijk Onderzoek016

    Keywords

    • Addiction
    • Functional annotation
    • GTEx
    • S-PrediXcan
    • Substance use
    • eQTLs

    Fingerprint

    Dive into the research topics of 'Post-GWAS analysis of six substance use traits improves the identification and functional interpretation of genetic risk loci'. Together they form a unique fingerprint.

    Cite this